E Nagura

453 total citations
45 papers, 274 citations indexed

About

E Nagura is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, E Nagura has authored 45 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 13 papers in Oncology and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in E Nagura's work include Multiple Myeloma Research and Treatments (11 papers), Acute Lymphoblastic Leukemia research (9 papers) and Acute Myeloid Leukemia Research (7 papers). E Nagura is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), Acute Lymphoblastic Leukemia research (9 papers) and Acute Myeloid Leukemia Research (7 papers). E Nagura collaborates with scholars based in Japan, Greece and Switzerland. E Nagura's co-authors include Kohei Kawashima, Kazumasa Yamada, Koichiro Kawashima, Nobuyuki Hamajima, Keisuke Yamada, Takuhei Murase, Toshiki Ohta, Kazuko Ishikawa‐Takata, N Horikoshi and Y Morishima and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer.

In The Last Decade

E Nagura

44 papers receiving 264 citations

Peers

E Nagura
Comparison fields: 5 of 66
  • Hematology 130
  • Public Health, Environmental and Occupational Health 80
  • Molecular Biology 76
  • Oncology 69
  • Genetics 46
B‐M Frost Sweden
D. W. Gorst United Kingdom
Maria Åström Sweden
Nosha Farhadfar United States
Tetsuo Hashida Japan
J Cubells Spain
Raquel De Paz Arias Spain
Mary Choroszy United States
Fabienne Trullemans Belgium
Faris Madanat Jordan
B‐M Frost Sweden View profile →
Citations per field, relative to E Nagura
E Nagura · 1×
Citations per year, relative to E Nagura
E Nagura · 1×

Countries citing papers authored by E Nagura

Since Specialization
Citations

This map shows the geographic impact of E Nagura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Nagura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Nagura more than expected).

Fields of papers citing papers by E Nagura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Nagura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Nagura. The network helps show where E Nagura may publish in the future.

Co-authorship network of co-authors of E Nagura

This figure shows the co-authorship network connecting the top 25 collaborators of E Nagura. A scholar is included among the top collaborators of E Nagura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Nagura. E Nagura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma Annals of Hematology Shuji Ozaki, Hiroshi Handa et al. 9
2 Primary Plasma Cell Leukemia in the Era of Novel Agents: A Multicenter Study of the Japanese Society of Myeloma Acta Haematologica Hirono Iriuchishima, Shuji Ozaki et al. 14
3 [Prognositic factors in multiple myeloma]. PubMed E Nagura 1
4 Posttreatment M‐Protein Nadir Level Is a Significant Prognostic Factor Associated with Survival in Multiple Myeloma Japanese Journal of Cancer Research Kazuyuki Shimizu, O Kamiya et al. 3
5 Analysis of Elderly Patients, Aged 60 Years Old or over, with Acute Lymphoblastic Leukemia. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics E Nagura, Saburo Minami et al. 10
6 Acute myeloid leukemia in the elderly:--159 Nagoya case studies--Nagoya Cooperative Study Group for Elderly Leukemia. PubMed E Nagura, Kaoru Nagata et al. 3
7 Characteristics of Bedridden Elderly People Living at Home and in a Hospital. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics E Nagura, A Igata et al. 2
8 An preliminary study on Quality of Life Scale for Elderly: An examination in terms of psychological satisfaction. The Japanese journal of psychology Hideo Yamada, Hidetoshi Endo et al. 5
9 Awareness and Feelings of Elderly Patients and Their Families Concerning Disease During Terminal Hospitalization. Malignancy versus Non-Malignancy. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics E Nagura, Hideki Endo et al. 1
10 Nation-wide randomized comparative study of doxorubicin, vincristine and prednisolone combination therapy with and without L-asparaginase for adult acute lymphoblastic leukemia Cancer Chemotherapy and Pharmacology E Nagura, Kiyoji Kimura et al. 31
11 Nation-wide randomized comparative study of doxorubicin, vincristine and prednisolone combination therapy with and without L-asparaginase for adult acute lymphoblastic leukemia Cancer Chemotherapy and Pharmacology E Nagura, Kiyoji Kimura et al. 4
12 Nationwide randomized comparative study of daunorubicin and aclarubicin in combination with behenoyl cytosine arabinoside, 6-mercaptopurine, and prednisolone for previously untreated acute myeloid leukemia Cancer Chemotherapy and Pharmacology E Nagura, Kiyoji Kimura et al. 7
13 A new myeloblastic leukemia cell line with double minute chromosomes. Induction of methotrexate resistance and dihydrofolate reductase gene amplification Leukemia Research Kenji Kishi, Miwako Narita et al. 8
14 Multi‐drug Combination Therapy with Vincristine‐Melphalan‐Cyclophosphamide‐Prednisolone Was More Effective than Cyclophosphamide‐Prednisolone in Stage III Myeloma Japanese Journal of Cancer Research Kazuyuki Shimizu, O Kamiya et al. 2
15 Malignant lymphoma compressing the heart and causing acute left-sided heart failure American Heart Journal Masatsugu Iwase, E Nagura et al. 11
16 Mechanism of Methotrexate‐sensitivity of Choriocarcinoma Cells in Culture Japanese Journal of Cancer Research E Nagura, Tetsuya Toyoda et al. 2
17 Identification and characterization of a unique tumor-associated surface antigen on L1210 leukemia cells recognized by semisyngeneic antisera. PubMed Takashi Yokochi, Kohei Kawashima et al. 5
18 [Secondary malignancies associated with hematological malignancies following anticancer treatment]. PubMed E Nagura, Koichiro Kawashima 1
19 The effects of multiple combination chemotherapy with vincristine, cyclophosphamide (Endoxan), methotrexate, 5-fluorouracil, adriamycin and prednisolone (VEMFAH) for advanced breast cancer Cancer Chemotherapy and Pharmacology Tetsuhito Kojima, Akira Hoshino et al. 0
20 Production of anti-self-H-2 antibodies by C3D2F1 mice hyperimmune to L cell/L1210 hybrids and L1210 leukemia cells Cellular Immunology Kohei Kawashima, Eiji Watanabe et al. 4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026